GSI Group Inc. (identified in the request as Novanta Inc.) — Q3 2013 Form 10-Q
Reporting period: Quarter ended September 27, 2013; year-to-date figures cover the nine months ended that date. The filing names the registrant as GSI Group Inc. and reports in U.S. dollars.
Business context and financial highlights
GSI designs and sells precision photonics and motion-control components and subsystems, primarily to OEMs in medical, industrial, electronics and scientific markets. Its two reportable segments are Laser Products and Precision Technologies. The January 2013 acquisition of NDS Surgical Imaging expanded the medical visualization business.
| Metric | Q3 2013 | Q3 2012 | Nine months 2013 | Nine months 2012 |
|---|---|---|---|---|
| Sales | $85.5m | $69.5m | $253.9m | $205.1m |
| Gross profit / margin | $35.8m / 41.9% | $28.9m / 41.5% | $103.5m / 40.7% | $87.2m / 42.5% |
| Operating income / margin | $5.7m / 6.7% | $3.8m / 5.5% | $11.0m / 4.3% | $11.7m / 5.7% |
| Income from continuing operations | $2.2m | $2.1m | $4.5m | $7.6m |
| Net income (loss) attributable to GSI | $1.8m | $(2.5)m | $3.0m | $3.7m |
| Diluted EPS attributable to GSI | $0.05 | $(0.07) | $0.09 | $0.11 |
| Cash from operating activities | — | $34.4m | $21.5m |
At September 27, cash was $53.7m and total debt was $78.4m, comprising $44.4m of term loans and $34.0m drawn on the revolver; net debt was approximately $24.7m. The company reported $41.0m of available revolver capacity and compliance with its debt covenants. Total assets were $377.9m and total liabilities were $144.6m.
Material changes versus comparable periods
- Sales increased 23.0% in Q3 and 23.8% year to date, largely because of NDS. Management attributed 21.0 and 24.2 percentage points of those increases, respectively, to the acquisition; organic growth was 3.0% in Q3 and 0.6% year to date.
- Q3 operating income rose 50.8%, helped by improved Laser Products performance and lower restructuring expense. Nine-month operating income declined 5.9%, as acquired-intangible amortization and NDS inventory fair-value step-up costs more than offset lower restructuring costs.
- Q3 diluted EPS from continuing operations remained $0.06; nine-month diluted EPS from continuing operations fell to $0.13 from $0.22. Higher tax expense contributed to the year-to-date decline.
- Operating cash flow improved, partly because of a $12.5m IRS refund. Investing cash outflow was $72.9m, principally reflecting the $82.7m NDS purchase, partly offset by proceeds from business and property sales. Cash declined by $12.1m from year-end 2012.
- Precision Technologies’ sales growth included NDS, while its gross margin fell to 42.6% in Q3 from 46.8% and to 42.0% year to date from 47.1%. Laser Products’ Q3 gross margin improved to 41.5% from 39.8%.
Outlook, risks and unusual items
- Management said operating cash flows should meet operating and investing needs for at least the next 12 months, with revolver availability as an additional liquidity source. This is a forward-looking statement, not a quantified earnings forecast; the filing provides no formal revenue or EPS guidance.
- The company expected $0.2m–$0.5m of additional cash restructuring charges in the remainder of 2013. It expected to complete legal-entity restructuring in the first half of 2014 and stated that the resulting structure should lower its effective tax rate.
- The Q3 effective tax rate was 42.6%, versus 21.5% a year earlier; the nine-month rate was 48.5%, versus 15.7%. Management cited jurisdictional tax differences and losses in jurisdictions with valuation allowances. It also noted that prior-year rates benefited from valuation-allowance utilization.
- The NDS purchase price was finalized at $80.8m after working-capital adjustments; $5.4m remained in escrow for potential indemnification claims through July 2014. Purchase accounting remained preliminary, including tax and liability valuations.
- In October 2013, after quarter-end, the board authorized a discretionary share-repurchase program of up to $10m. The company also reported an appeal in a French legal matter; management did not consider a loss probable and recorded no accrual.
- Key disclosed business risks include cyclical customer capital spending, limited organic growth, acquisition integration, foreign exchange, customer concentration, debt service and the ability to realize acquired intangible-asset values. Management reported disclosure controls were effective at quarter-end.
Investor facts to verify
- Confirm the issuer identity and corporate history: this filing is for GSI Group Inc., although the request identifies Novanta Inc.
- Separate acquisition-driven growth from organic performance, particularly in Precision Technologies, and assess NDS integration and profitability.
- Track gross-margin pressure, amortization and inventory step-up effects, and whether management’s expected tax-rate reduction materializes.
- Reconcile operating cash flow with the one-time IRS refund, working-capital requirements, acquisition spending, debt levels and available revolver capacity.
- Monitor the remaining NDS purchase-accounting adjustments, escrow claims, restructuring costs, French litigation appeal and any execution of the authorized buyback.